Stock Price Quote

LUPIN LABORATORIES LTD. (AMALGAMATED)

NSE : NABSE : 500258ISIN CODE : INE327A01019Industry : UnspecifiedHouse : Private
BSE77.750 (0 %)
PREV CLOSE ( ) 77.75
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1972
Management Info
- Chairman - Managing Director
Registered Office

Address 159, C S T Road,Kalina,Santacruz East,
Mumbai,
Maharashtra-400098

Phone 91-022-26528311/26391

Email NA

Website  

Registrars Details
Not Available
Listing : BSE, NSE

NEWS

09Aug Lupin, Infibeam Avenues and Satin Cred
Lupin’s wholly-owned subsidiary -- Novel Laboratories Inc., based in Som..
27Apr Lupin in pact with Abbott Labs, Labora
Lupin and its subsidiaries have entered into a licence agreement with Ab..

Financials

in Millions
QTR Dec 00 ANNUAL 00
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

No Data Found

Shareholding Pattern

No Data Found

About

no data found

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.